Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:55 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 385–408 of 4,558 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: obesity Clear all

Conditions: HIV Infections
Interventions: Doravirine 100 Mg, Integrase strand transfer inhibitors, Tenofovir alafenamide/emtricitabine, tenofovir disproxil fumarate/emtricitabine; Drug
Lead sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections; Network
Eligibility: 18 Years and older
Enrollment: 147 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 27
States / cities: Birmingham, Alabama • Los Angeles, California • San Diego, California + 21 more

Conditions: Idiopathic Intracranial Hypertension
Interventions: Acetazolamide, Placebo, Formal weight loss counselling program; Drug · Behavioral
Lead sponsor: St. Luke's-Roosevelt Hospital Center; Other
Eligibility: 18 Years to 60 Years
Enrollment: 165 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2014
U.S. locations: 39
States / cities: Birmingham, Alabama • Los Angeles, California • Waterbury, Connecticut + 31 more

Conditions: Obesity, Metabolic Syndrome
Interventions: Pioglitazone, Placebo; Drug
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 63 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2016
U.S. locations: 2
States / cities: Baton Rouge, Louisiana

Conditions: Obesity, Morbid
Interventions: vBloc Maestro Rechargeable System; Device
Lead sponsor: ReShape Lifesciences; Industry
Eligibility: 18 Years and older
Enrollment: 125 participants
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: Lone Tree, Colorado • Newark, Delaware

Conditions: Nausea and Vomiting, Obesity
Interventions: Tradipitant, Placebo; Drug
Lead sponsor: Vanda Pharmaceuticals; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 280 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 10
States / cities: Los Angeles, California • San Diego, California • San Jose, California + 7 more

Conditions: Psoriasis, Obesity
Interventions: Ixekizumab, Tirzepatide; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 281 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 68
States / cities: Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 57 more

Conditions: Obesity, Substance Abuse
Interventions: Yappalli; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older · Female only
Enrollment: 174 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2022
U.S. locations: 1
States / cities: McAlester, Oklahoma

Conditions: Obesity, Hypertension, Depression
Interventions: 6 week challenge with 1 year of home visits: health texting, in home exercise supports, social support, healthy eating and feeding classes; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: Female only
Enrollment: 175 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Pregnancy, Obesity, Weight Gain, Obstetric Complications
Interventions: Lifestyle intervention; Behavioral
Lead sponsor: St. Louis University; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Obesity, Childhood
Interventions: Tylenol; Drug
Lead sponsor: Children's National Research Institute; Other
Eligibility: 10 Years to 18 Years
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2025
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Overweight Adolescents
Interventions: gamified mHealth lifestyle app, Attention Control, gamified mHealth app with financial incentives; Other
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 13 Years to 15 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Childhood Obesity
Interventions: Meal replacement and lifestyle modification; Other
Lead sponsor: Ann & Robert H Lurie Children's Hospital of Chicago; Other
Eligibility: 11 Years to 15 Years
Enrollment: 260 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Healthy
Interventions: Voriconazole low dose, Voriconazole high dose; Drug
Lead sponsor: Manjunath Prakash Pai; Other
Eligibility: 18 Years to 50 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Paramus, New Jersey

Conditions: Obesity
Interventions: Evaluate Healthy Lifestyle Program on cognitive outcomes; Behavioral
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 65 Years and older
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Obesity
Interventions: sibutramine; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 65 Years
Enrollment: 181 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Obesity
Interventions: Not listed
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 2,458 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2016
U.S. locations: 9
States / cities: New York, New York • Greenville, North Carolina • Fargo, North Dakota + 3 more

Conditions: Obesity, Overweight, Chronic Weight Management
Interventions: Aleniglipron, Placebo; Drug
Lead sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics; Industry
Eligibility: 18 Years to 79 Years
Enrollment: 3,600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 71
States / cities: Birmingham, Alabama • Phoenix, Arizona • Sun City West, Arizona + 64 more

Conditions: Obesity
Interventions: Metabolic & Bariatric Surgery; Procedure
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 35 Years to 60 Years · Female only
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Morbid Obesity
Interventions: Laparoscopic Greater Curvature Plication; Procedure
Lead sponsor: Singh, Kuldeep, M.D., P.A.; Individual
Eligibility: 18 Years to 65 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Narcolepsy
Interventions: Not listed
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years to 55 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2013
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Obesity, Overweight, Weight Loss
Interventions: self-monitoring of body weight, self-monitoring of diet, weekly personalized feedback + lessons + action plans; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 21 Years to 65 Years
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Obesity
Interventions: Sandostatin LAR; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 6 Years to 18 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2004
U.S. locations: 15
States / cities: Phoenix, Arizona • Orange, California • San Francisco, California + 12 more

Conditions: Cardiac Surgery, Sternal Wound Infection
Interventions: gentamicin-collagen sponge dipped in saline; Drug
Lead sponsor: Innocoll; Industry
Eligibility: 18 Years and older
Enrollment: 1,502 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 43
States / cities: Birmingham, Alabama • Florence, Alabama • Pasadena, California + 39 more

Conditions: Child Obesity, Breast Feeding, Feeding Behavior, Nutrition, Healthy
Interventions: StEP OUT; Behavioral
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older · Female only
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: New Hyde Park, New York

Search by objective public record fields.

Doravirine for Obese Persons on Integrase Inhibitors and Tenofovir Alafenamide

Idiopathic Intracranial Hypertension Treatment Trial

Cellular Dynamics of Subcutaneous Fat Distribution in Obese Women

vBloc Now - Registry

A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use

Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight

Yappalli - The Road to Choctaw Health

Postpartum Weight Retention

Lifestyle Intervention Forever: Healthy Weight for Pregnancy and Birth (Pilot Study)

Acetaminophen Dosing in Obese Adolescents

CommitFit App to Facilitate Health Behavior Change in Clinic Adolescents

Adaptive Mechanisms Responsible for Weight Change in Youth With Obesity

Pharmacokinetics of Voriconazole in Obese Subjects

Evaluation of the Healthy Lifestyle Program on Cognitive Outcomes

Weight Loss in Response to Sibutramine (MERIDIA) is Influenced by the Inherited Genes

Long-term Effects of Bariatric Surgery

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

The Effects of Metabolic & Bariatric Surgery on Lipid Metabolism, Myeloid-Derived Suppressor Cells, and Cancer Cell Biology

Resolution of Comorbidities & Safety and Efficacy of Greater Curvature Plication in Obese Patients

Body Weight Regulation in Patients With Narcolepsy

GoalTracker: Comparing Self-Monitoring Strategies for Weight Loss

Pediatric Hypothalamic Obesity

Safety and Efficacy of an Antibiotic Implant in Cardiac Surgical Subjects at Higher Risk for Sternal Wound Infection

Starting Early to Prevent Obesity Using Telehealth (StEP OUT): Intervention Development Trial